Nightingale Health Oyj (HEL: HEALTH)
Finland
· Delayed Price · Currency is EUR 2.740
+0.050 (1.86%)
At close: Dec 20, 2024
Nightingale Health Oyj Income Statement
Financials in millions EUR. Fiscal year is July - June.
Millions EUR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2017 |
| Revenue | 4.36 | 4.36 | 4.18 | 2.31 | 2.31 | 1.78 | Upgrade
|
| Revenue Growth (YoY) | 4.21% | 4.21% | 80.80% | 0.35% | 29.43% | -13.67% | Upgrade
|
| Cost of Revenue | 1.46 | 1.46 | 0.59 | 1.04 | 0.32 | 1.65 | Upgrade
|
| Gross Profit | 2.9 | 2.9 | 3.59 | 1.28 | 1.99 | 0.13 | Upgrade
|
| Selling, General & Admin | 8.78 | 8.78 | 9.38 | 6.5 | 6.37 | 0.07 | Upgrade
|
| Other Operating Expenses | 4.51 | 4.51 | 6.01 | 4.14 | 3.05 | 3.18 | Upgrade
|
| Operating Expenses | 21.46 | 21.46 | 22.08 | 14.89 | 11.87 | 3.47 | Upgrade
|
| Operating Income | -18.56 | -18.56 | -18.49 | -13.61 | -9.88 | -3.34 | Upgrade
|
| Interest Expense | -0.01 | -0.01 | -0 | -0.77 | -0.37 | -0.39 | Upgrade
|
| Interest & Investment Income | - | - | - | - | - | 0 | Upgrade
|
| Earnings From Equity Investments | -0.03 | -0.03 | -0.03 | -0.02 | 0.13 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.27 | -0.27 | -0.37 | 0.3 | -0.06 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 1.5 | 1.5 | 0.82 | -0.03 | 0.46 | -0 | Upgrade
|
| EBT Excluding Unusual Items | -17.38 | -17.38 | -18.07 | -14.13 | -9.72 | -3.73 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -2.07 | - | - | Upgrade
|
| Pretax Income | -17.38 | -17.38 | -18.07 | -16.19 | -9.72 | -3.73 | Upgrade
|
| Income Tax Expense | 0.09 | 0.09 | 0.01 | -0.1 | 0 | 0 | Upgrade
|
| Net Income | -17.46 | -17.46 | -18.08 | -16.09 | -9.73 | -3.73 | Upgrade
|
| Net Income to Common | -17.46 | -17.46 | -18.08 | -16.09 | -9.73 | -3.73 | Upgrade
|
| Shares Outstanding (Basic) | 61 | 61 | 61 | 60 | 42 | 34 | Upgrade
|
| Shares Outstanding (Diluted) | 61 | 61 | 61 | 60 | 42 | 34 | Upgrade
|
| Shares Change (YoY) | - | - | 1.13% | 44.56% | 22.85% | - | Upgrade
|
| EPS (Basic) | -0.29 | -0.29 | -0.30 | -0.27 | -0.23 | -0.11 | Upgrade
|
| EPS (Diluted) | -0.29 | -0.29 | -0.30 | -0.27 | -0.23 | -0.11 | Upgrade
|
| Free Cash Flow | -10.62 | -10.62 | -8.16 | -8.85 | -2.77 | -11.35 | Upgrade
|
| Free Cash Flow Per Share | -0.17 | -0.17 | -0.13 | -0.15 | -0.07 | -0.33 | Upgrade
|
| Gross Margin | 66.45% | 66.45% | 85.89% | 55.17% | 86.16% | 7.19% | Upgrade
|
| Operating Margin | -425.86% | -425.86% | -442.16% | -588.46% | -428.59% | -187.68% | Upgrade
|
| Profit Margin | -400.71% | -400.71% | -432.40% | -695.68% | -421.91% | -209.51% | Upgrade
|
| Free Cash Flow Margin | -243.62% | -243.62% | -195.17% | -382.49% | -120.04% | -637.40% | Upgrade
|
| EBITDA | -14.06 | -14.06 | -14.96 | -11.53 | -9.3 | -3.34 | Upgrade
|
| EBITDA Margin | - | - | - | - | - | -187.50% | Upgrade
|
| D&A For EBITDA | 4.5 | 4.5 | 3.53 | 2.08 | 0.58 | 0 | Upgrade
|
| EBIT | -18.56 | -18.56 | -18.49 | -13.61 | -9.88 | -3.34 | Upgrade
|
| EBIT Margin | - | - | - | - | - | -187.68% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.